Streetbeat News

Analyst Ratings

GFF

Stephens & Co. analyst Trey Grooms has reiterated an Overweight rating on Griffon (NYSE:GFF) and maintained a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:19 pm

KEY

Keefe, Bruyette & Woods analyst David Konrad maintains an Outperform rating on KeyCorp with a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:18 pm

CBU

Keefe, Bruyette & Woods analyst Christopher O'Connell has maintained a Market Perform rating on Community Financial (NYSE:CBU) with a price target of $59.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:15 pm

RLAY

Relay Therapeutics shares fell after Oppenheimer downgraded the stock from Outperform to Perform.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:14 pm

TERN

Terns Pharmaceuticals shares are experiencing an increase in trading activity following JMP Securities' decision to raise its price target from $15 to $20.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:12 pm

MEOH

Methanex shares fell after Barclays downgraded the stock from Overweight to Equal-Weight and reduced its price target from $56 to $44.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:09 pm

PL

Goldman Sachs analyst Noah Poponak maintains a Buy rating on Planet Labs but lowers the price target from $3.5 to $3.1.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:05 pm

CMA

Stephens & Co. analyst Terry McEvoy has reiterated an Overweight rating on Comerica (NYSE:CMA) and maintained a price target of $58.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 2:04 pm

DK

EQR

JCI

ORCL

RLAY

Top Wall Street analysts have upgraded their ratings for several companies, including Oracle, Johnson Controls, Equity Residential, Delek US Holdings, and Relay Therapeutics. These upgrades reflect positive outlooks and increased price targets for these stocks.

Portfolio Pulse from Avi Kapoor

September 10, 2024 | 2:03 pm

PRG

Analysts have provided mixed ratings for PROG Holdings (NYSE:PRG) over the past three months, with a recent increase in the average 12-month price target to $48.8. The company's financial performance shows challenges in revenue growth and net margin, but strong ROE and ROA.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 2:01 pm